Societal Implications › Implementation: Comparing Regulatory Frameworks with Data
Language AI HandbookAll chapters Societal Implications › Implementation: Comparing Regulatory Frameworks with DataOne section · Sections in this chapter6 / 10 ↓
Reading tools Definitions & inline links
Choose your expertise level to adjust how many terms are explained. Beginners see more tooltips, experts see fewer to maintain reading flow. Hover over underlined terms for instant definitions.
Article links
Make inline references clickable
To make these abstract governance concepts concrete, we can construct a simple analysis of how different regulatory frameworks treat AI applications across several dimensions.
# Illustrative mapping of AI applications to regulatory treatment
# across major jurisdictions
applications = [
"Hiring Screening",
"Medical Diagnosis",
"Generative AI (general)",
"Law Enforcement\nFacial Recognition",
"Credit Scoring",
"Educational Assessment",
"News Content Generation",
"Criminal Recidivism\nPrediction",
]
# Risk level assigned (1=minimal, 2=limited, 3=high, 4=banned)
eu_risk = [3, 3, 2, 4, 3, 3, 2, 3]
us_federal_risk = [2, 2, 1, 2, 2, 1, 1, 2]
# 1=no specific rules, 2=existing law applies, 3=guidance, 4=restricted
# Print summary statistics from the regulatory analysis
eu_avg = np.mean(eu_risk)
us_avg = np.mean(us_federal_risk)
eu_banned = sum(1 for r in eu_risk if r == 4)
eu_high_risk = sum(1 for r in eu_risk if r >= 3)
us_restricted = sum(1 for r in us_federal_risk if r >= 3)EU average risk level across applications: 2.9/4.0 US average regulatory treatment level: 1.6/4.0 Applications banned by EU: 1 Applications classified high-risk or banned by EU: 6 Applications subject to specific guidance or restriction in US: 0
The quantitative comparison confirms the qualitative pattern: the EU assigns substantially higher risk classifications to the same applications, showing a more precautionary approach. The US approach, based on applying existing legal frameworks rather than AI-specific risk classifications, produces lower average regulatory burden but also less consistent coverage. Practitioners working across both jurisdictions must comply with substantially different requirements, and the compliance costs of operating under the stricter EU framework effectively apply to any organization serving EU users.
It is worth emphasizing what this data does not show. Regulatory treatment and actual deployment outcomes are not the same thing. High regulatory classification does not guarantee that harms are prevented; it means that additional requirements apply before and after deployment. Similarly, low regulatory classification does not mean that harm is absent; it means that existing general-purpose legal frameworks apply rather than AI-specific rules. Whether the EU's stricter classification produces better outcomes for EU residents than the US approach produces for US residents is an empirical question that will only be answerable with years of data on AI deployment outcomes in both contexts.